• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Black Book Ranks Veradigm EHR the #1 Ambulatory EHR for Family Practice and Primary Care Practices

    2/3/25 8:01:00 AM ET
    $MDRX
    EDP Services
    Technology
    Get the next $MDRX alert in real time by email

    EHR solution receives top rankings for ease of navigation, telehealth integration and client experience, amplifying company's commitment to supporting ambulatory provider practices 

    Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book Research, a leader in healthcare industry insights, has ranked Veradigm EHR first for both Ambulatory EHR Family Practice and Ambulatory EHR Primary Care General Practice in its 2025 Top-Rated EHR Vendors by Specialty. The prestigious rating solidifies Veradigm's commitment to designing technology for providers, empowering informed patient care, streamlined workflows and enhanced operational efficiencies, amidst the continuous industry regulatory changes.

    This Black Book list, based on a comprehensive nine month survey of 33,516 respondents across the U.S., recognizes the leading EHR companies within various medical specialties for their innovative solutions, exceptional performance, and user satisfaction. The survey includes feedback from medical professionals, practice managers, and administrators, offering insights into the most effective and reliable solutions that help streamline operations, improve patient care, and enhance clinical workflows.

    "High-performing EHR vendors excel because they embody agility in adapting to regulatory shifts, interoperability that breaks down data silos, patient-centric innovations that redefine engagement, and efficiency that streamlines practice workflows," said Doug Brown, President of Black Book Research. "These attributes position them as indispensable partners, empowering physicians to thrive in an increasingly complex and tech-driven healthcare landscape."

    Veradigm EHR is a robust platform that has grown with tens of thousands of providers nationwide for decades. With Veradigm's easy navigation and telehealth integration, the company achieved a 9.3 out of 10, translating to a 93% client experience rating. Today's healthcare providers are busier than ever, often overburdened with administrative tasks - a key contributor of burnout - while simultaneously working to navigate the shift to value-based care. By prioritizing provider needs and innovation to deliver improved experience, including the recent launch of Veradigm Ambient Scribe, Veradigm continues its commitment to improving the daily lives of providers.

    "We are honored to be recognized by Black Book Research's distinguished rating, including first for both Ambulatory EHR Family Practice and Primary Care General Practice. Veradigm is committed to providing tools that help clinicians deliver better patient care, whether through streamlined documentation, improved access to patient data, or more integrated care coordination," said Tom Langan, Interim Chief Executive Officer of Veradigm. "Veradigm EHR is continuously evolving based on user feedback and we are committed to maintaining high standards. With the recognition driven by customer responses, we're excited by the validation that our processes are working to transform healthcare insightfully for providers."

    About Veradigm®

    Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully. For more information on Veradigm, visit http://www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.

    © 2025 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or company names are the property of their respective holders, all rights reserved.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250203328651/en/

    Investors:

    Jenny Gelinas

    312-506-1237

    [email protected]

    Media:

    Concetta Rasiarmos

    630-740-3152

    [email protected]

    Get the next $MDRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MDRX

    DatePrice TargetRatingAnalyst
    3/19/2024$15.00 → $10.00Buy → Hold
    Deutsche Bank
    1/3/2024$11.00Equal Weight
    Barclays
    7/6/2023Buy → Hold
    Argus
    4/12/2023$13.00Equal-Weight
    Stephens
    2/1/2023$17.00 → $18.50Overweight → Neutral
    Piper Sandler
    12/7/2022$26.00Hold → Buy
    Argus
    11/9/2022$22.00 → $23.00Neutral → Buy
    Goldman
    11/4/2022$17.00Overweight
    Piper Sandler
    More analyst ratings

    $MDRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

    Veradigm (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research. Built on Veradigm's FollowMyHealth patient engagement platform, the capability enables individuals to securely share their experiences through an account they own and manage. Patients receive project‑specific invitations through trusted channels within FollowMyHealt

    2/13/26 8:01:00 AM ET
    $MDRX
    EDP Services
    Technology

    Veradigm to Release Business Update February 17th and Host Investor Call February 18th

    Veradigm® (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company's update at 8:00 a.m. Eastern Time on February 18, 2026. Update Call Details Veradigm plans to issue a press release after the close of regular stock market hours on Tuesday, February 17, 2026. The announcement will also be available at Veradigm investor relations website. To listen to the conference call, participants may log onto the Veradigm invest

    2/10/26 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology

    Veradigm Extends Stockholder Rights Plan

    Veradigm® (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that its Board of Directors (the "Board") has approved an amendment to extend the Company's existing Stockholder Rights Plan to December 31, 2026 (the "Rights Plan"). The Board's decision to extend the Rights Plan is based on its determination that many of the underlying risks and conditions that existed upon the initial adoption of the Rights Plan will continue to be present beyond February 20, 2026. Accordingly, the Rights Plan is being extended to continue to ensure that all Veradigm stockholders have the opportunity to realize the full potential value of their in

    2/2/26 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology

    $MDRX
    SEC Filings

    View All

    Veradigm Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Veradigm Inc. (0001124804) (Filer)

    2/17/26 4:10:26 PM ET
    $MDRX
    EDP Services
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Veradigm Inc.

    SCHEDULE 13G/A - Veradigm Inc. (0001124804) (Subject)

    2/13/26 1:08:01 PM ET
    $MDRX
    EDP Services
    Technology

    Amendment: SEC Form 8-A12G/A filed by Veradigm Inc.

    8-A12G/A - Veradigm Inc. (0001124804) (Filer)

    2/2/26 4:47:45 PM ET
    $MDRX
    EDP Services
    Technology

    $MDRX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Stonehill Capital Management Llc bought $66,001,500 worth of shares (10,222,875 units at $6.46) (SEC Form 4) (Amendment)

    4/A - Veradigm Inc. (0001124804) (Issuer)

    3/15/24 5:16:45 PM ET
    $MDRX
    EDP Services
    Technology

    Stonehill Capital Management Llc bought $66,001,500 worth of shares (10,222,875 units at $6.46) (SEC Form 4)

    4 - Veradigm Inc. (0001124804) (Issuer)

    3/4/24 9:50:46 PM ET
    $MDRX
    EDP Services
    Technology

    $MDRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP & Chief HR Officer Hammond Lisa was granted 58,140 shares, increasing direct ownership by 50% to 174,175 units (SEC Form 4)

    4 - Veradigm Inc. (0001124804) (Issuer)

    6/5/25 5:28:24 PM ET
    $MDRX
    EDP Services
    Technology

    SVP General Counsel Vakharia Tejal was granted 69,768 shares, increasing direct ownership by 22% to 387,476 units (SEC Form 4)

    4 - Veradigm Inc. (0001124804) (Issuer)

    6/5/25 5:22:40 PM ET
    $MDRX
    EDP Services
    Technology

    Director Sacks Jonathan S was granted 46,512 shares and converted options into 8,696 shares (SEC Form 4)

    4 - Veradigm Inc. (0001124804) (Issuer)

    6/3/25 9:28:21 PM ET
    $MDRX
    EDP Services
    Technology

    $MDRX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Veradigm downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded Veradigm from Buy to Hold and set a new price target of $10.00 from $15.00 previously

    3/19/24 7:50:39 AM ET
    $MDRX
    EDP Services
    Technology

    Barclays initiated coverage on Veradigm with a new price target

    Barclays initiated coverage of Veradigm with a rating of Equal Weight and set a new price target of $11.00

    1/3/24 8:00:02 AM ET
    $MDRX
    EDP Services
    Technology

    Veradigm downgraded by Argus

    Argus downgraded Veradigm from Buy to Hold

    7/6/23 9:00:49 AM ET
    $MDRX
    EDP Services
    Technology

    $MDRX
    Financials

    Live finance-specific insights

    View All

    Veradigm to Release Business Update February 17th and Host Investor Call February 18th

    Veradigm® (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company's update at 8:00 a.m. Eastern Time on February 18, 2026. Update Call Details Veradigm plans to issue a press release after the close of regular stock market hours on Tuesday, February 17, 2026. The announcement will also be available at Veradigm investor relations website. To listen to the conference call, participants may log onto the Veradigm invest

    2/10/26 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology

    Veradigm Amends and Extends Stockholder Rights Plan

    Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, today announced that its Board of Directors (the "Board") has approved an amendment to extend the Company's existing Stockholder Rights Plan for an additional six months (the "Rights Plan"). The Rights Plan, adopted on February 26, 2024, was due to expire at 5:00PM New York City time on August 20, 2025. Under the terms of the amendment to the Rights Plan, the scheduled expiration date of the Rights Plan has been extended to February 20, 2026. In addition, the amendment to the Rights Plan changes the triggering threshold such that the rights would become exercisable only if a person or group acquires bene

    8/20/25 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology

    Veradigm to Release Business Update June 23rd and Host Investor Call June 24th

    Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, announced today that management plans to provide a business update after the close of regular stock market hours on June 23, 2025. Veradigm management plans to host an investor conference call and webcast the Company's update at 8:00 a.m. Eastern Time on June 24, 2025. Update Call Details Veradigm plans to distribute an announcement promptly after the close of regular stock market hours on Monday, June 23, 2025. The announcement will also be available at Veradigm investor relations website. To listen to the conference call, participants may log onto the Veradigm investor relations website. Participan

    6/18/25 5:27:00 PM ET
    $MDRX
    EDP Services
    Technology

    $MDRX
    Leadership Updates

    Live Leadership Updates

    View All

    Veradigm Appoints Tehsin Syed as Chief Product and Technology Officer

    Healthcare IT Veteran - former AWS and Cerner senior executive - to lead and accelerate innovation across Veradigm's unique footprint Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, today appoints Tehsin Syed, a healthcare technology leader with over two decades of experience, as Chief Product and Technology Officer. Syed most recently served as General Manager, AWS Health AI (Amazon Web Services). Under his leadership, the organization scaled as a growth engine, with net-new products for ambient clinical documentation, genomics, and medical imaging, and interoperability elevated to enterprise grade - capabilities trusted by providers, payers, bioph

    11/3/25 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology

    Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors

    Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors NEW YORK, Sept. 25, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ: PAVM), today announced the appointment of accomplished healthcare executive John R. Palumbo to its Board of Directors, effective September 22, 2025. "John is a highly accomplished executive whose 40 years of healthcare leadership experience spans earl

    9/25/25 8:01:00 AM ET
    $LUCD
    $MDRX
    $PAVM
    Medical/Dental Instruments
    Health Care
    EDP Services
    Technology

    Veradigm Announces Appointment of Two New Independent Directors and Transition of Board Leadership

    Appoints Jonathan Sacks and Bruce Felt to the Board Lou Silverman to Succeed Greg Garrison as Chairman Veradigm Inc. (OTC:MDRX) ("Veradigm" or the "Company"), a leading provider of healthcare data and technology solutions, announced today its Board of Directors (the "Board") appointed two new independent directors, Jonathan Sacks and Bruce Felt, to the Board, effective March 19, 2025, and that Lou Silverman will succeed Greg Garrison as Chairman upon his retirement from the Board on that date. In addition, Mr. Felt will become the Chair of the Audit Committee of the Board upon Mr. Garrison's retirement. Further, independent director Vinit Asar has been named Chair of the Nominating and Go

    3/18/25 4:47:00 PM ET
    $CMBM
    $DOMO
    $EVH
    Radio And Television Broadcasting And Communications Equipment
    Technology
    Computer Software: Prepackaged Software
    Other Consumer Services

    $MDRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Veradigm Inc.

    SC 13G - Veradigm Inc. (0001124804) (Subject)

    11/14/24 4:05:58 PM ET
    $MDRX
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Veradigm Inc.

    SC 13G/A - Veradigm Inc. (0001124804) (Subject)

    11/14/24 1:11:13 PM ET
    $MDRX
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Veradigm Inc.

    SC 13G/A - Veradigm Inc. (0001124804) (Subject)

    11/8/24 10:29:29 AM ET
    $MDRX
    EDP Services
    Technology